Detailed Information on Publication Record
2021
The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis-Randomized study
ANDRAŠINA, Tomáš, Tomáš ROHAN, Jiří PÁNEK, Petra KOVALČÍKOVÁ, Lumír KUNOVSKÝ et. al.Basic information
Original name
The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis-Randomized study
Authors
ANDRAŠINA, Tomáš (703 Slovakia, belonging to the institution), Tomáš ROHAN (203 Czech Republic, belonging to the institution), Jiří PÁNEK (203 Czech Republic, belonging to the institution), Petra KOVALČÍKOVÁ (203 Czech Republic, belonging to the institution), Lumír KUNOVSKÝ (203 Czech Republic, belonging to the institution), Lenka OSTŘÍŽKOVÁ (203 Czech Republic, belonging to the institution) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution)
Edition
European journal of radiology, Ireland, Elsevier Science Ireland Ltd, 2021, 0720-048X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30224 Radiology, nuclear medicine and medical imaging
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.531
RIV identification code
RIV/00216224:14110/21:00122392
Organization unit
Faculty of Medicine
UT WoS
000687783200001
Keywords in English
Endoluminal ablation; Intraductal ablation; Bile duct stenosis; Radiofrequency ablation; Biliary metal stent
Tags
International impact, Reviewed
Změněno: 31/1/2022 07:01, Mgr. Tereza Miškechová
Abstract
V originále
Purpose: To analyse whether endobiliary radiofrequency ablation prior metal stent insertion in malignant biliary stenosis show improved survival or stent patency. Methods: 76 patients with histologically proven malignant biliary stenosis have been enrolled in a prospective, randomized study. In control arm, 40 patients underwent self-expandable metal stent insertion. In experimental arm, the endoluminal ablation with a bipolar radiofrequency catheter was performed immediately before stent insertion. A subgroup analysis of cholangiocarcinoma was performed (22 vs 21 patients). The objective of the study was to determine the rate of complications, duration of the stent patency and the survival of patients (Kaplan-Meier analysis). Results: No major complications related to the stent insertion and the endoluminal ablation were found. The mean primary stent patency was 5.2 (95% CI 0.7-12.8) vs 4.8 months (95% CI 0.8-18.2) months (p = 0.79) in control and experimental group, respectively, in the subgroup analysis with cholangiocarcinoma 4.5 (95% CI 0.8-10.3) and 9.6 (95% CI 5.2-11.2) months (p = 0.029). The median survival since the insertion of the stent was 6.8 (95 %CI 3.0-10.6) vs 5.2 (95 %CI 2.4-7.9) months (p = 0.495) and since the initial drainage 9.8 (95 %CI 6.9-12.7) vs 9.1 (95 %CI 5.4-12.7) months (p = 0.720) in the control and experimental arm. Conclusion: Endobiliary radiofrequency ablation prior metal stent insertion showed increased patency rate only in patients with cholangiocarcinoma, on the other hand, no improvement in survival was demonstrated in this randomized clinical study.
Links
MUNI/A/1342/2020, interní kód MU |
|